Loading Events

« All Events

  • This event has passed.

Cardiovascular and Renal Drugs Advisory Committee

December 10, 2019 @ 8:00 am - 5:00 pm

The committee will be asked to discuss new drug application (NDA) 022034, for vernakalant HCl solution, for intravenous injection, submitted by Correvio International Sàrl, for the proposed indication of rapid conversion of recent onset atrial fibrillation to sinus rhythm for non-surgery patients: Atrial fibrillation ≤ 7 days duration, and for post-cardiac surgery patients: Atrial fibrillation ≤ 3 days duration.


December 10, 2019
8:00 am - 5:00 pm
Event Category: